在肝细胞癌中胎重编程:将发育计划与癌症疫苗和免疫治疗联系起来
Dayangku Nordiyana B P Hassanel1,2, Ankur Sharma1,2,3
1Translational Genomics Program, Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, NSW 2010, Australia.
Clinical and molecular hepatology
|March 4, 2026
概括
肝细胞癌 (HCC) 治疗正在通过向子宫生态系统来推进. 包括mRNA疫苗在内的新策略旨在克服免疫逃避,以获得更好的肝癌免疫治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 发展生物学 发展生物学
背景情况:
- 肝细胞癌 (HCC) 是一种流行的主要肝癌,死亡率高.
- 瘤的发病包括内在的异质性和免疫抑制性瘤微环境 (TME).
- 瘤表现出胎儿的重编程,重新表达胎儿抗原,并改变树皮/免疫细胞,促进免疫逃避.
研究的目的:
- 审查对HCC的胎儿重编程的机制性见解.
- 评估针对胎儿生态系统的治疗策略.
- 讨论新疗法的潜力,包括mRNA疫苗,用于HCC治疗.
主要方法:
- 对HCC中胎儿重编程的当前文献的综述.
- 对针对胎儿抗原的新兴治疗策略的分析.
- 对疫苗平台,细胞疗法和生物制剂的评估.
主要成果:
- 胎重编程驱动免疫逃避,并影响HCC的治疗反应.
- mRNA-脂质纳米粒子 (LNP) 疫苗在诱导持久的抗瘤免疫力方面表现有前途.
- 正在探索将疫苗与免疫检查点抑制剂结合在一起的组合策略.
结论:
- 针对胎内生态系统对于有效的HCC治疗至关重要.
- 克服肝脏耐受性和抗原异质性对于成功的胎导向治疗至关重要.
- 协调的疫苗,细胞和免疫治疗策略为改善HCC治疗反应和免疫治疗效益提供了途径.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.6K
08:17The In Ovo Chick Chorioallantoic Membrane CAM Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma
Published on: October 9, 2015
37.2K
相关概念视频
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K